Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation

Detalhes bibliográficos
Autor(a) principal: Donato, José. L.
Data de Publicação: 1996
Outros Autores: Marcondes, Sisi, Antunes, Edson, Nogueira, Marie Doki [UNIFESP], Dietrich, Carl Peter [UNIFESP], Rendu, F., deNucci, G., Nader, Helena Bonciani [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.1996.tb16057.x/full
http://repositorio.unifesp.br/handle/11600/43181
Resumo: 1 Proteoglycans provide negatively charged sites on the surface of platelets, leukocytes and endothelial cells. Since chrondroitin 4-sulphate is the main proteoglycan present on the platelet surface, the role of this molecule in mediating the activation of human platelets by polylysine was studied. 2 Platelets were desensitized with phorbol 12-myristate 13-acetate (PMA, 10 nm) 5 min before the addition of polylysine to platelet-rich plasma (PRP). Changes in the intracellular Ca2+ concentration were measured in fura-2-am (2 mu M) loaded platelets and protein phosphorylation was assessed by autoradiography of the electrophoretic profile obtained from [P-32]-phosphate labelled platelets. The release of dense granule contents was measured in [C-14]-5-hydroxytryptamine loaded platelets and the synthesis of thromboxane (TXA(2)) was assessed by radioimmunoassay. Surface chrondroitinase AC (3 min, 37 degrees C). The amount of chondroitin-4-sulphate remained in the platelets was then quantified after proteolysis and agarose gel electrophoresis.3 The addition of PMA to PRP before polylysine inhibited the aggregation by 88+/-18% (n=3). Staurosporine (1 mu M, 5 min) prevented the PMA-induced inhibition. Chrondroitinase AC (4 pu ml(-1) to 400 mu u ml(-1), 3 min) abolished the polylysine-induced aggregation in PRP but caused only a discrete inhibition of ADP-induced aggregation. The concentration of chrondroitin 4-sulphate in PRP (0.96+/-0.2 mu g/10(8) platelets, n=3) and in washed platelets (WP; 0.35+/-0.1 mu g/10(8) platelets, n=3) was significantly reduced following incubation with chondroitinase AC (PRP=0.63+/-01 mu g/10(8) platelets and WP=0.08+/-0.06 mu g/10(8) platelets).4 Washed platelets had a significantly lower concentration of chrondroitin 4-sulphate than platelets in PRP. The addition of polylysine to WP induced a rapid increase in light transmission which was not accompanied by TXA(2) synthesis or the release of dense granule contents. This effect was not inhibited by sodium nitroprusside (SNP), iloprost, EDTA or the peptide RGDS. This event was accompanied by the discrete phosphorylation of plekstrin and myosin light chain, which were inhibited by staurosporine (10 mu M, 10 min). The hydrolysis of platelet surface chondroitin 4-sulphate strongly reduced the polylysine-induced phosphorylation.5 Our results indicate that polylysine activates platelets through a specific receptor which could be the proteoglycan chrondroitin 4-sulphate present on the platelet membrane.
id UFSP_be032916d2ba141e371f549afd00b304
oai_identifier_str oai:repositorio.unifesp.br/:11600/43181
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregationchondroitin 4-sulphatepolylysineprotein phosphorylationphorbol 12-myristate 13-acetate (PMA)calcium mobilization1 Proteoglycans provide negatively charged sites on the surface of platelets, leukocytes and endothelial cells. Since chrondroitin 4-sulphate is the main proteoglycan present on the platelet surface, the role of this molecule in mediating the activation of human platelets by polylysine was studied. 2 Platelets were desensitized with phorbol 12-myristate 13-acetate (PMA, 10 nm) 5 min before the addition of polylysine to platelet-rich plasma (PRP). Changes in the intracellular Ca2+ concentration were measured in fura-2-am (2 mu M) loaded platelets and protein phosphorylation was assessed by autoradiography of the electrophoretic profile obtained from [P-32]-phosphate labelled platelets. The release of dense granule contents was measured in [C-14]-5-hydroxytryptamine loaded platelets and the synthesis of thromboxane (TXA(2)) was assessed by radioimmunoassay. Surface chrondroitinase AC (3 min, 37 degrees C). The amount of chondroitin-4-sulphate remained in the platelets was then quantified after proteolysis and agarose gel electrophoresis.3 The addition of PMA to PRP before polylysine inhibited the aggregation by 88+/-18% (n=3). Staurosporine (1 mu M, 5 min) prevented the PMA-induced inhibition. Chrondroitinase AC (4 pu ml(-1) to 400 mu u ml(-1), 3 min) abolished the polylysine-induced aggregation in PRP but caused only a discrete inhibition of ADP-induced aggregation. The concentration of chrondroitin 4-sulphate in PRP (0.96+/-0.2 mu g/10(8) platelets, n=3) and in washed platelets (WP; 0.35+/-0.1 mu g/10(8) platelets, n=3) was significantly reduced following incubation with chondroitinase AC (PRP=0.63+/-01 mu g/10(8) platelets and WP=0.08+/-0.06 mu g/10(8) platelets).4 Washed platelets had a significantly lower concentration of chrondroitin 4-sulphate than platelets in PRP. The addition of polylysine to WP induced a rapid increase in light transmission which was not accompanied by TXA(2) synthesis or the release of dense granule contents. This effect was not inhibited by sodium nitroprusside (SNP), iloprost, EDTA or the peptide RGDS. This event was accompanied by the discrete phosphorylation of plekstrin and myosin light chain, which were inhibited by staurosporine (10 mu M, 10 min). The hydrolysis of platelet surface chondroitin 4-sulphate strongly reduced the polylysine-induced phosphorylation.5 Our results indicate that polylysine activates platelets through a specific receptor which could be the proteoglycan chrondroitin 4-sulphate present on the platelet membrane.UNIFESP,ESCOLA PAULISTA MED,DEPT BIOQUIM,BR-04044020 SAO PAULO,BRAZILUNIV FORMAT & RECH PHARM,U428 INSERM,PARIS,FRANCEUNIFESP,ESCOLA PAULISTA MED,DEPT BIOQUIM,BR-04044020 SAO PAULO,BRAZILWeb of ScienceStockton PressUniversidade Federal de São Paulo (UNIFESP)UNIV FORMAT & RECH PHARMDonato, José. L.Marcondes, SisiAntunes, EdsonNogueira, Marie Doki [UNIFESP]Dietrich, Carl Peter [UNIFESP]Rendu, F.deNucci, G.Nader, Helena Bonciani [UNIFESP]2018-06-15T16:24:08Z2018-06-15T16:24:08Z1996-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion1447-1453http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.1996.tb16057.x/fullBritish Journal Of Pharmacology. Basingstoke: Stockton Press, v. 119, n. 7, p. 1447-1453, 1996.0007-1188http://repositorio.unifesp.br/handle/11600/43181WOS:A1996VW40500021engBritish Journal Of Pharmacologyinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-05-02T15:52:09Zoai:repositorio.unifesp.br/:11600/43181Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-05-02T15:52:09Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation
title Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation
spellingShingle Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation
Donato, José. L.
chondroitin 4-sulphate
polylysine
protein phosphorylation
phorbol 12-myristate 13-acetate (PMA)
calcium mobilization
title_short Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation
title_full Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation
title_fullStr Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation
title_full_unstemmed Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation
title_sort Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation
author Donato, José. L.
author_facet Donato, José. L.
Marcondes, Sisi
Antunes, Edson
Nogueira, Marie Doki [UNIFESP]
Dietrich, Carl Peter [UNIFESP]
Rendu, F.
deNucci, G.
Nader, Helena Bonciani [UNIFESP]
author_role author
author2 Marcondes, Sisi
Antunes, Edson
Nogueira, Marie Doki [UNIFESP]
Dietrich, Carl Peter [UNIFESP]
Rendu, F.
deNucci, G.
Nader, Helena Bonciani [UNIFESP]
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
UNIV FORMAT & RECH PHARM
dc.contributor.author.fl_str_mv Donato, José. L.
Marcondes, Sisi
Antunes, Edson
Nogueira, Marie Doki [UNIFESP]
Dietrich, Carl Peter [UNIFESP]
Rendu, F.
deNucci, G.
Nader, Helena Bonciani [UNIFESP]
dc.subject.por.fl_str_mv chondroitin 4-sulphate
polylysine
protein phosphorylation
phorbol 12-myristate 13-acetate (PMA)
calcium mobilization
topic chondroitin 4-sulphate
polylysine
protein phosphorylation
phorbol 12-myristate 13-acetate (PMA)
calcium mobilization
description 1 Proteoglycans provide negatively charged sites on the surface of platelets, leukocytes and endothelial cells. Since chrondroitin 4-sulphate is the main proteoglycan present on the platelet surface, the role of this molecule in mediating the activation of human platelets by polylysine was studied. 2 Platelets were desensitized with phorbol 12-myristate 13-acetate (PMA, 10 nm) 5 min before the addition of polylysine to platelet-rich plasma (PRP). Changes in the intracellular Ca2+ concentration were measured in fura-2-am (2 mu M) loaded platelets and protein phosphorylation was assessed by autoradiography of the electrophoretic profile obtained from [P-32]-phosphate labelled platelets. The release of dense granule contents was measured in [C-14]-5-hydroxytryptamine loaded platelets and the synthesis of thromboxane (TXA(2)) was assessed by radioimmunoassay. Surface chrondroitinase AC (3 min, 37 degrees C). The amount of chondroitin-4-sulphate remained in the platelets was then quantified after proteolysis and agarose gel electrophoresis.3 The addition of PMA to PRP before polylysine inhibited the aggregation by 88+/-18% (n=3). Staurosporine (1 mu M, 5 min) prevented the PMA-induced inhibition. Chrondroitinase AC (4 pu ml(-1) to 400 mu u ml(-1), 3 min) abolished the polylysine-induced aggregation in PRP but caused only a discrete inhibition of ADP-induced aggregation. The concentration of chrondroitin 4-sulphate in PRP (0.96+/-0.2 mu g/10(8) platelets, n=3) and in washed platelets (WP; 0.35+/-0.1 mu g/10(8) platelets, n=3) was significantly reduced following incubation with chondroitinase AC (PRP=0.63+/-01 mu g/10(8) platelets and WP=0.08+/-0.06 mu g/10(8) platelets).4 Washed platelets had a significantly lower concentration of chrondroitin 4-sulphate than platelets in PRP. The addition of polylysine to WP induced a rapid increase in light transmission which was not accompanied by TXA(2) synthesis or the release of dense granule contents. This effect was not inhibited by sodium nitroprusside (SNP), iloprost, EDTA or the peptide RGDS. This event was accompanied by the discrete phosphorylation of plekstrin and myosin light chain, which were inhibited by staurosporine (10 mu M, 10 min). The hydrolysis of platelet surface chondroitin 4-sulphate strongly reduced the polylysine-induced phosphorylation.5 Our results indicate that polylysine activates platelets through a specific receptor which could be the proteoglycan chrondroitin 4-sulphate present on the platelet membrane.
publishDate 1996
dc.date.none.fl_str_mv 1996-12-01
2018-06-15T16:24:08Z
2018-06-15T16:24:08Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.1996.tb16057.x/full
British Journal Of Pharmacology. Basingstoke: Stockton Press, v. 119, n. 7, p. 1447-1453, 1996.
0007-1188
http://repositorio.unifesp.br/handle/11600/43181
WOS:A1996VW40500021
url http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.1996.tb16057.x/full
http://repositorio.unifesp.br/handle/11600/43181
identifier_str_mv British Journal Of Pharmacology. Basingstoke: Stockton Press, v. 119, n. 7, p. 1447-1453, 1996.
0007-1188
WOS:A1996VW40500021
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv British Journal Of Pharmacology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1447-1453
dc.publisher.none.fl_str_mv Stockton Press
publisher.none.fl_str_mv Stockton Press
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268409577209856